ArticleFrontiers in oncology2025
Comparative analysis of pancreatic cancer burden attributable to high BMI in adults aged 70 and older: analysis of the GBD data in the United States, Australia, and Germany (2012-2021).
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pancreatic cancer (PC) is a highly lethal malignancy for which obesity is a major risk factor. With increasing global aging, the burden of PC is increasing in the elderly population. Objective: The objective of this study was to analyze the association between high body mass index (BMI) and the burden of PC in people aged 70 years and older in the United States of America (USA), Australia, and Germany during 2012-2021. Methods: BMI-related PC mortality and disability-adjusted life years (DALYs) were extracted from the global burden of disease (GBD) 2021 database for people aged 70 years and older. Trends in the burden of disease were assessed using age-standardized rate (ASR), estimated annual percentage change (EAPC), and joinpoint regression analyses, and differences between the three countries were compared. Results: From 2012 to 2021, BMI-related PC mortality and DALYs increased in all three countries, with the steepest rise in the USA (ASR from 3.12 to 3.65), followed by Australia (ASR from 2.05 to 2.65), and a relatively stable trend in Germany (ASR from 1.81 to 2.26). The increase was most pronounced in adults aged 70 years and older, with average annual growth rates of 3.05% in Australia, 0.55% in Germany (after 2019), and 1.71% in the USA. BMI-related PC mortality patterns varied by country: males had higher rates than females in the USA, while Germany showed the opposite trend. In Australia, men aged 70-74 had higher BMI-related PC mortality than women, but women had higher rates in all other age groups. All three countries exhibited rising BMI-related PC rates with age, though peak incidence occurred at different ages. Conclusion: High BMI significantly increases PC burden in adults aged 70 years and older in the USA, Australia, and Germany. Countries should tailor obesity prevention and health management strategies to their specific contexts to address the health challenges of an aging society.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.